Suki Moving Upmarket to Health Systems

Suki is moving upmarket because AI scribes stop being simple software once a hospital wants them wired into the core record system. Selling one doctor a note taking tool can be a fast subscription sale, but selling a health system means security review, business associate agreements, and deep EHR integration. That trade gives Suki larger contracts, more seats per win, and a better path to become part of the clinical workflow instead of a standalone app.

• The small practice motion is real, but capped. In this market, individual clinicians and tiny groups can buy quickly, yet budgets are tight and many can only spend around tens to low hundreds per month. Enterprise buyers move slower, but one contract can cover an entire medical group or hospital system.
  1 sacra 3 sacra
• The gating factor is integration depth. An AI scribe that only drafts a note can work as a light tool, but large systems want the product to pull chart context, write back into the EHR, fill structured fields, and support billing and compliance workflows. That makes hospital sales an IT and operations sale, not just a physician sale.
  1 sacra 4 sacra
• The market is splitting by go to market and EHR alignment. Freed has grown fast with a $99 per month self serve model for individual clinicians, while enterprise players like Abridge have gained an edge through tight Epic relationships. Suki's platform strategy adds another route, by embedding its voice AI inside other healthcare software vendors.
  2 sacra 3 sacra 5 sacra

The next phase is a race to own more of the documentation stack inside major health systems. As scribes expand from ambient notes into orders, coding, pre charting, and nursing workflows, the winners will be the companies that pair strong clinician experience with deep EHR connections and broad distribution across hospitals and software partners.